FDA approves Quixin generic

AMITYVILLE, N.Y. — The Food and Drug Administration has approved Hi-Tech Pharmacal’s generic version of a drug for eye infections.

Hi-Tech announced the approval of levofloxacin ophthalmic solution in the 0.5% strength, a treatment for bacterial conjunctivitis. The company plans to launch next month.

The drug is a generic version of Vistakon’s Quixin, which had sales of $2 million in 2010, according to IMS Health.